European Commission's Scientific Committee Sets Out Five-Year Focus For Medical Devices
This article was originally published in SRA
Executive Summary
The use of nanomaterials and endocrine disruptors in medical devices are among the main work items for the European Commission's Scientific Committee on Health Environmental and Emerging Risks over its next, five-year term (2016-2021), it emerged at the inaugural meeting of the newly created committee on April 28-291.